Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Diabetes Health Reference Charts
A1c Test Archives
Print | Email | Share | Comments (0)

Lantus Combined With Oral Meds Can Save Your Patients Money


Apr 1, 2006

From the Spring Research Guide

For people with type 2, Lantus in combination with oral medications can be a cost-equivalent alternative to conventional insulin therapy.

Researchers at the University Clinic for Internal Medicine in Innsbruck, Austria, obtained data from a patient population of 678 patients with type 2. The patients were not able to adequately control their type 2 with oral medications alone. Patients received either Lantus in addition to oral therapy or were switched to conventional insulin therapy and were followed for two to four months.

The researchers say the two therapeutic regimens were equally effective in decreasing A1C. Total daily costs of insulin, needles, blood glucose-monitoring devices (such as meters and test strips) and oral meds per patient were similar in the two treatment groups, amounting in American dollars to about $2.31 per day in the Lantus group versus $2.41 per day in the conventional group.

“The two treatment regimens were equally effective in improving [blood glucose] control,” say the researchers. “These results were achieved with significantly lower insulin doses and fewer blood glucose test strips in the [Lantus] group, which therefore led to cost equivalence when compared with conventional insulin therapy.”

Wiener klinische Wochenschrift, September 2005


Categories: A1c Test, Blood Glucose, Insulin, Lantus, Professional Issues, Research, Type 2 Issues



You May Also Be Interested In...


Comments


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.